Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolbetuximab Plus mFOLFOX6 or CAPOX in Indian Participants With Advanced Gastric or GEJ Cancer
NCT07829757Phase 4Not yet recruiting
- Sponsor
- Astellas Pharma
- Start
- Nov 2026
- Primary completion
- Jul 2029
01
Overview
A Phase 4 trial of zolbetuximab in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Astellas Pharma. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
zolbetuximab
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT07829757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07829757.